Aptevo Therapeutics Inc (APVO) is not a strong buy at the moment for a beginner investor with a long-term strategy. The lack of positive financial performance, absence of significant trading trends, and no clear technical or sentiment-based catalysts make it prudent to hold off on purchasing this stock right now.

Technical Analysis

The stock's MACD is positive and expanding, indicating a potential upward momentum. However, the RSI is neutral at 61.672, and moving averages are converging, suggesting no strong directional trend. The stock is trading near its resistance level (R1: 7.483), which could limit further immediate upside.

Positive Catalysts

NULL identified. No recent news, no significant hedge fund or insider trading activity, and no congress trading data available.

Neutral/Negative Catalysts

Additionally, no recent news or trading trends suggest positive momentum.

Financial Performance

In Q3 2025, revenue remained at 0 with no YoY growth. Net income improved YoY but is still significantly negative at -$9.028M. EPS dropped sharply by -99.38% YoY, and gross margin remains at 0. Overall, financial performance is weak.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No data available for analyst ratings or price target changes.

Analyst Rating

Wall Street analysts forecast APVO stock price to rise

Buy

Hold

Sell

Current: 7.320

Low

Averages

High